Parkinson disease trials in Mexico

3 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

  Where

  Mexico City

  Age

  50 years to 85 years

  People

  900 worldwide

  Run by

  Hoffmann-La Roche

  See details and how to joinNCT07174310 · EU 2025-522683-32-00
• No phaseEnrolling by invitation
  Real World Outcomes of Intranasal MuSE Exosomes and Stem Cells in Neurological Regenerative Therapy

  Where

  Monterrey

  Age

  4 years to 80 years

  People

  36

  Run by

  Healing Hope International

  See details and how to joinNCT07521384
• No phaseTaking people
  Proteinopathies Expression in Skin of Neurodegenerative Disorders

  Where

  San Luis Potosí City

  Age

  45 years and over

  People

  40

  Run by

  Universidad Autonoma de San Luis Potosí

  See details and how to joinNCT06528964